Skip to main content
. 2011 Jun 9;11:165. doi: 10.1186/1471-2334-11-165

Figure 3.

Figure 3

Analysis of HBsAg clearance and HBsAg seroconversion between PEG-IFNα+LAM combination therapy and PEG-IFNα monotherapy (high-quality studies).